Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Bae: AZT/3TC/NVP vs d4T/3TC/NVP

Maternal Grade 3/4 Severe Adverse Events · HIV‐Infected Pregnant Women With CD4<350

It is very uncertain whether jamisse (What to Start): AZT/3TC/NVP changes maternal Grade 3/4 Severe Adverse Events compared with d4T/3TC/NVP (very low certainty).

1 finding from 1 review

Antiretroviral therapy (ART) for treating HIV infection in ART‐eligible pregnant women 2010 · Cochrane Headline outcomes only
RR 1.58 [0.6, 4.12]
1 study · 146 participants
Very low